Torrent Pharma delivered a textbook quarter — revenues up 18 per cent year-on-year to Rs 33 billion, profits climbing 26 per cent to Rs 6.4 billion, and EBITDA margins nudging up 40 basis points to 32.9 per cent. In the ordinary course of business, that would have been the headline. But this is no ordinary … Read more
A GST-driven margin surprise and accelerating sales has brokerages agree the growth story has legs Britannia Industries is back in a sweet spot. The country’s largest biscuit maker delivered a margin performance in Q3FY26 that surprised even optimistic analysts, while a new chief executive has arrived with an ambitious agenda of brand investment, inorganic acquisitions, … Read more
Pharma major’s 284 bps EBITDA margin gain and Unichem turnaround strategy draw bullish analyst calls IPCA Laboratories has emerged as a growth story in India’s pharmaceutical sector with two leading brokerages issuing buy recommendations following the company’s third-quarter performance that showcased margin expansion even as revenue growth remained modest. The Mumbai-based drugmaker’s ability to expand … Read more
Four main board IPOs have lined up IPOs, but will they see enough subscription? The primary market is bracing for a busy fortnight with four mainboard initial public offerings aggregating Rs 5,700 crore set to open for subscription, even as Monday’s twin listings of Fractal Analytics and Aye Finance delivered a sobering reminder that investor … Read more
With Nifty IT down 15% in a month and FCF yields at crisis levels, analysts ask: Is this a Kodak moment or a generational buying opportunity? The question haunting Dalal Street’s technology corner isn’t whether AI will disrupt Indian IT services. It’s whether the disruption has already been priced in — and then some. The … Read more
A 50% revenue surge and 400% profit jump have made analysts sit up and take notice When a mid-cap jewellery stock delivers revenue growth of 50% and profit growth north of 400% in a single quarter, you’d expect analysts to be tripping over themselves. Senco Gold’s Q3FY26 results has driven BOB Capital Markets which has … Read more
Lupin has delivered the goods this quarter. When a pharmaceutical company beats estimates across revenue, margins, and profit in a single quarter, investors tend to sit up. When it does so by margins wide enough to force analysts to revise their numbers upward, the question shifts from “is this good?” to “is this sustainable?” Lupin … Read more
Uttar Pradesh is rolling out the welcome mat for alcohol manufacturers, and it could change the fortunes of two home grown brewers. When India’s largest state decides to roll out the welcome mat for alcohol manufacturers, investors would do well to pour themselves a drink and pay attention. Uttar Pradesh, a market of over 230 … Read more
India’s Rs 2 lakh+ crore IPO pipeline faces a reality check as Sensex loses 3,000 points in nine days Two hundred companies. Over Rs 2 lakh crore in combined fundraising ambitions. Another 100-odd awaiting clearance for nearly Rs 1.4 lakh crore more. An unprecedented 244 draft red herring prospectuses were filed in 2025 alone — … Read more
There is a particular kind of market injustice reserved for companies that do everything right at the wrong time. Jubilant Foodworks — the company that runs Domino’s Pizza in India and a growing international portfolio — just delivered a quarter that answered every question bears had been asking. Like-for-like growth held up on a … Read more